<?xml version="1.0" encoding="UTF-8"?>
<p>Recombinant feline interferon-ω (rFeIFN-ω), the corresponding feline interferon, is licensed for use in veterinary medicine in Japan, Australia, and some European countries. It can be used in cats for long periods without antibody development, and no major severe side effects have been reported [
 <xref rid="B107-vetsci-02-00456" ref-type="bibr">107</xref>].
</p>
